Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
The New Zealand Medical Journal
|
February 25, 2006
PHARMAC's response on clopidogrel
Peter Moodie, Sean Dougherty
Health Services Insights
|
July 5, 2022
Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries
Luca Lorenzoni, Sean Dougherty
The New Zealand Medical Journal
|
November 16, 2005
PHARMAC responds on long-acting inhalers for COPD
Scott Metcalfe, Sean Dougherty
BMJ (Clinical Research Ed.)
|
February 11, 2003
Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Celecoxib's relative gastrointestinal safety is overstated
Scott Metcalfe, Sean Dougherty, Wayne McNee
The New Zealand Medical Journal
|
June 30, 2006
PHARMAC and EpiPen for anaphylaxis
Peter Moodie, Scott Metcalfe, Sean Dougherty
The New Zealand Medical Journal
|
July 27, 2006
PHARMAC and statins--getting the best population health gains
Peter Moodie, Sean Dougherty, Scott Metcalfe
The New Zealand Medical Journal
|
December 24, 2005
PHARMAC responds on treatments for pulmonary arterial hypertension
Scott Metcalfe, Dilky Rasiah, Sean Dougherty
International Journal of Paleopathology
|
February 27, 2022
And as things have been they remain: Enteric disease and differential mortality among ethnic groups in early twentieth century Milwaukee
Norman Sullivan, Noel Hincha, Sydney Resler, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 17, 2021
The impact of decentralisation on the performance of health care systems: a non-linear relationship
Sean Dougherty, Luca Lorenzoni, Alberto Marino, et al.
The New Zealand Medical Journal
|
March 27, 2003
PHARMAC measures savings elsewhere to the health sector
Scott Metcalfe, Sean Dougherty, Matthew Brougham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
The New Zealand Medical Journal
|
February 25, 2006
PHARMAC's response on clopidogrel
Peter Moodie, Sean Dougherty
Health Services Insights
|
July 5, 2022
Understanding Differences in Health Care Spending: A Comparative Study of Prices and Volumes Across OECD Countries
Luca Lorenzoni, Sean Dougherty
The New Zealand Medical Journal
|
November 16, 2005
PHARMAC responds on long-acting inhalers for COPD
Scott Metcalfe, Sean Dougherty
BMJ (Clinical Research Ed.)
|
February 11, 2003
Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Celecoxib's relative gastrointestinal safety is overstated
Scott Metcalfe, Sean Dougherty, Wayne McNee
The New Zealand Medical Journal
|
June 30, 2006
PHARMAC and EpiPen for anaphylaxis
Peter Moodie, Scott Metcalfe, Sean Dougherty
The New Zealand Medical Journal
|
July 27, 2006
PHARMAC and statins--getting the best population health gains
Peter Moodie, Sean Dougherty, Scott Metcalfe
The New Zealand Medical Journal
|
December 24, 2005
PHARMAC responds on treatments for pulmonary arterial hypertension
Scott Metcalfe, Dilky Rasiah, Sean Dougherty
International Journal of Paleopathology
|
February 27, 2022
And as things have been they remain: Enteric disease and differential mortality among ethnic groups in early twentieth century Milwaukee
Norman Sullivan, Noel Hincha, Sydney Resler, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
October 17, 2021
The impact of decentralisation on the performance of health care systems: a non-linear relationship
Sean Dougherty, Luca Lorenzoni, Alberto Marino, et al.
The New Zealand Medical Journal
|
March 27, 2003
PHARMAC measures savings elsewhere to the health sector
Scott Metcalfe, Sean Dougherty, Matthew Brougham, et al.
Page
of 2